Table 3 Survival time, significance and log-rank test for the study population for different characteristics of children during 5 year of follow-up (Kaplan–Meier method) of children on ART at East Gojjam zone public hospitals, Northwest Ethiopia, 2019
Covariates | Survival time per month, (95% CI) | Log-rank test (p–value) | |
|---|---|---|---|
Mean ± SE | 95% (CI) | ||
Age in month | |||
< 12 | 39.12 ± 4.25 | 30.80–47.45 | 19.54 (0.000) |
12–59 | 50.31 ± 2.52 | 45.38–55.25 | |
≥ 60 | 57.27 ± 4.69 | 55.92–58.63 | |
Sex | |||
Male | 55.64 + 0.94 | 53.80–57.48 | 2.08 (0.149) |
Female | 54.38 + 1.38 | 51.67–57.09 | |
Residence | |||
Urban | 54.98 ± 1.16 | 52.70–57.25 | 0.87 (0.351) |
Rural | 55.48 ± 1.09 | 53.33–57.62 | |
CD4 count | |||
Below threshold | 48.15 ± 2.47 | 43.32–52.20 | 21.90(< 0.001) |
Above threshold | 57.79 ± 0.60 | 56.61–58.96 | |
Hemoglobin level | |||
< 10 mg/dl | 47.20 ± 2.84 | 41.63–52.76 | 25.23 (< 0.001) |
≥ 10 mg/dl | 57.56 ± 0.64 | 56.31–58.81 | |
WHO HIV stage | |||
Stage I | 57.04 ± 1.11 | 54.87–59.21 | 10.23 (0.017) |
Stage II | 55.85 ± 1.22 | 53.47–58.23 | |
Stage III | 54.31 ± 1.57 | 51.23–57.40 | |
Stage IV | 42.97 ± 3.18 | 36.73–49.21 | |
Functional status ≥ 5 years | |||
Working/functional | 58.20 ± 0.56 | 57.11–59.30 | 46.96 (< 0.001) |
Bedridden | 37.50 ± 5.14 | 27.42–47.58 | |
Ambulatory | 57.12 ± 0.87 | 55.41–58.83 | |
Developmental status (< 5yrs) | |||
Appropriate | 44.49 ± 2.80 | 39.00–49.98 | 603 (0.819) |
Delayed | 36.25 ± 3.28 | 29.83–42.67 | |
Regressed | 24.50 ± 4.60 | 15.49–33.51 | |
Weight for height | |||
Normal | 57.22 ± 0.71 | 55.82–58.62 | 17.02 (0.000) |
Moderate wasting | 52.57 ± 2.08 | 48.49 -56.64 | |
Severe wasting | 38.60 ± 5.04 | 28.73–48.48 | |
Weight for age | |||
Normal | 57.10 ± 0.76 | 55.61–58.59 | 15.10 (0.001) |
Moderate underweight | 53.455 ± 1.76 | 50.01–56.91 | |
Severe underweight | 41.20 ± 5.03 | 31.33–51.06 | |
Height for age | |||
Normal | 57.17 ± 0.73 | 55.73–58.60 | 21.79 (< 0.001) |
Moderate stunting | 53.19 ± 1.86 | 49.54–56.83 | |
Severe stunting | 36.67 ± 5.79 | 25.33–48.01 | |
CPT | |||
Yes | 57.47 ± 0.68 | 56.14–58.79 | 10.6 (0.001) |
No | 51.06 ± 1.93 | 47.27–54.85 | |
ART adherence | |||
Good | 56.97 ± 0.70 | 55.60–58.35 | 29.33(< 0.001) |
Fair | 43.34 ± 2.47 | 38.49–48.1 | |
Poor | 39.16 ± 4.36 | 30.61–47.70 | |
Drug side effect | |||
Yes | 52.26 ± 1.81 | 48.70–55.81 | 0.004 (0.95) |
No | 55.55 ± 0.96 | 53.67–57.42 | |
Regimen change | |||
Yes | 45.67 ± 4.36 | 37.12–54.23 | 15. 10 (0.000) |
No | 56.45 ± 0.75 | 54.99–57.92 | |